Canopy Growth Corp (WEED.TO)
2.39
-0.05
(-2.05%)
CAD |
TSX |
Mar 30, 14:00
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 1.225B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -75.70% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 2.371 |
| Price to Book Value | 0.8594 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.8457 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 96.05% |
News
Headline
Wire
Time (ET)
MT Newswires
03/29 07:41
MT Newswires
03/29 07:41
MT Newswires
03/22 17:08
MT Newswires
03/22 17:07
MT Newswires
03/21 09:03
MT Newswires
03/16 07:03
Yahoo
03/14 13:50
MT Newswires
03/14 08:04
Events
| DATE | TIME | TYPE | PERIOD | REPORTED EPS |
ESTIMATED EPS |
SURPRISE | |
| 05/26/2023* | 10:00 EST | Earnings Call | Q4 2023 | -- | -- | -- | |
| 05/26/2023* | -- | Results | Q4 2023 | -- | -- | -- | |
| 02/09/2023 | 10:00 EST | Earnings Call | Q3 2023 | -- | -- | -- | |
| 02/09/2023 | -- | Results | Q3 2023 | -0.46 | -0.23 | -102.4% | |
| 11/09/2022 | 10:00 EST | Earnings Call | Q2 2023 | -- | -- | -- | |
| 11/09/2022 | -- | Results | Q2 2023 | -0.33 | -0.26 | -26.58% | |
| 08/05/2022 | 10:00 EST | Earnings Call | Q1 2023 | -- | -- | -- | |
| 08/05/2022 | -- | Results | Q1 2023 | -0.87 | -0.28 | -209.5% |
*Estimated Date/Time
Earnings
Profile
| Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization. |
| URL | https://www.canopygrowth.com |
| Investor Relations URL | https://www.canopygrowth.com/ |
| HQ State/Province | Ontario |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Equity Style | Small Cap/Value |
| Next Earnings Release | May. 26, 2023 (est.) |
| Last Earnings Release | Feb. 09, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Dividends
| Dividend Per Share (TTM) | -- |
|
2017
2018
2019
2020
2021
6.00%
4.00%
2.00%
|
|
| Yield to Market | 0.00 |
| Yield to Sector | 0.00 |
| Yield to Industry | 0.00 |
| Last Dividend Amt. | -- |
| Dividend Frequency | -- |
| Last Ex-Dividend Date | -- |
| Yield (TTM) | 0% |
| Forward Yield | -- |
| Payout Ratio | 0.00% |
| Cash Payout Ratio | 0.00% |
| Consistent Payer (5Y) | No |
| Consistent Growth (5Y) | No |
Risk
Total Returns Comparison
Annual Total Returns Versus Peers
As of March 29, 2023.
Fundamentals
| Revenue (TTM) | 440.96M |
| Total Expenses (TTM) | 1.070B |
| Net Income (TTM) | -3.141B |
| Total Assets (Quarterly) | 3.020B |
| Total Liabilities (Quarterly) | 1.580B |
| Shareholders Equity (Quarterly) | 1.426B |
| Cash from Operations (TTM) | -544.50M |
| Cash from Investing (TTM) | 644.05M |
| Cash from Financing (TTM) | -145.12M |
Ratings
Profile
| Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization. |
| URL | https://www.canopygrowth.com |
| Investor Relations URL | https://www.canopygrowth.com/ |
| HQ State/Province | Ontario |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Equity Style | Small Cap/Value |
| Next Earnings Release | May. 26, 2023 (est.) |
| Last Earnings Release | Feb. 09, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ownership
| Insider Ownership Percentage | Upgrade |
Jul '20
Nov '20
Mar '21
80.00%
40.00%
10.00%
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Other Resources
| Yahoo Finance | Insider Trading |
| Yahoo Finance | Institutional Ownership |
| TMX Money | Option Chain |
| SEC | SEC Filings |
| WEED.TO Tweets |